Professor Minghao Zheng, a past president of the International Chinese Musculoskeletal Research Society (ICMRS) and a world-renowned leader in orthopaedic research, has been elected as a 2025 Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).

This prestigious appointment is one of Australia's highest honors in the health and medical sciences, recognizing Professor Zheng's outstanding contributions and exceptional leadership in translating scientific discoveries into clinical practice.

Professor Zheng serves as the Winthrop Professor of Orthopaedic Research at the University of Western Australia and leads the Bone and Brain Axis Research division at the Perron Institute for Neurological and Translational Science. He is also the co-founder and Chief Scientific Officer of Orthocell.

His election to the AAHMS celebrates a distinguished career dedicated to regenerative medicine. Professor Zheng is globally recognized for pioneering innovative therapies for musculoskeletal injuries. His discoveries have led to new medical devices and cell-based products to repair cartilage, bone, and nerve injuries. His research has transformed understanding of musculoskeletal disease by revealing that giant cells in bone tumours are non-tumour cells (enabling non-surgical treatment), identifying obesity-linked pathological changes in osteoarthritis, and uncovering mitochondrial transfer as a key process for tissue homeostasis. His innovations have improved treatment outcomes for patients in Australia, the United States, and Europe. 

The ICMRS community and his colleagues worldwide extend their warmest congratulations to Professor Zheng on this well-deserved honor, which underscores his profound impact on regenerative medicine and patient care.